Pitcairn Co. Takes $197,000 Position in Takeda Pharmaceutical Company Limited (NYSE:TAK)
Pitcairn Co. bought a new position in shares of Takeda Pharmaceutical Company Limited (NYSE:TAK – Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 14,201 shares of the company’s stock, valued at approximately $197,000. Other hedge funds have also recently bought and […]
More Stories
Financial Review: Alarm.com (NASDAQ:ALRM) versus Alarum Technologies (NASDAQ:ALAR)
Alarm.com (NASDAQ:ALRM – Get Free Report) and Alarum Technologies (NASDAQ:ALAR – Get Free Report) are both industrial products companies, but...
Trump Says US Will Take Back Control of Panama Canal If US Interests Threatened
By Melanie Sun President-elect Donald Trump has said he will take back control of the Panama Canal from the nation’s...
Comparing Bath & Body Works (BBWI) & Its Competitors
Bath & Body Works (NYSE:BBWI – Get Free Report) is one of 27 publicly-traded companies in the “Retail stores, not...
Bion Environmental Technologies (OTCMKTS:BNET) Shares Cross Below 50-Day Moving Average – Here’s What Happened
Bion Environmental Technologies, Inc. (OTCMKTS:BNET – Get Free Report)’s share price passed below its 50-day moving average during trading on...
Market Vectors Chinese Renminbi/USD ETN (NYSEARCA:CNY) Shares Cross Below 50-Day Moving Average – Here’s What Happened
Market Vectors Chinese Renminbi/USD ETN (NYSEARCA:CNY – Get Free Report) shares crossed below its 50-day moving average during trading on...
Tiziana Life Sciences (LON:TILS) Share Price Passes Above 50-Day Moving Average – Should You Sell?
Tiziana Life Sciences PLC (LON:TILS – Get Free Report) passed above its 50-day moving average during trading on Friday ....